0001440766-11-000003.txt : 20111206
0001440766-11-000003.hdr.sgml : 20111206
20111206090918
ACCESSION NUMBER: 0001440766-11-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111205
FILED AS OF DATE: 20111206
DATE AS OF CHANGE: 20111206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dingivan Christine A
CENTRAL INDEX KEY: 0001440766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27570
FILM NUMBER: 111244555
MAIL ADDRESS:
STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CENTRAL INDEX KEY: 0001003124
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 561640186
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
BUSINESS PHONE: 9102510081
MAIL ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2011-12-05
1
0001003124
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
PPDI
0001440766
Dingivan Christine A
929 NORTH FRONT STREET
WILMINGTON
NC
28401
0
1
0
0
EVP/Chief Medical Officer
Stock Options (to buy)
27.27
2011-12-05
4
D
0
45000
0
D
Common Stock
45000
0
D
Stock Option (to buy)
26.64
2011-12-05
4
D
0
20000
0
D
Common Stock
20000
0
D
Stock Option (to buy)
20.45
2011-12-05
4
D
0
41403
0
D
Common Stock
41403
0
D
Stock Options (to buy)
25.74
2011-12-05
4
D
0
31052
0
D
Common Stock
31052
0
D
Stock Options (to buy)
19.94
2011-12-05
4
D
0
7763
0
D
Common Stock
7763
0
D
Stock Options (to buy)
37.69
2011-12-05
4
D
0
7763
0
D
Common Stock
7763
0
D
Stock Options (to buy)
36.65
2011-12-05
4
D
0
93156
0
D
Common Stock
93156
0
D
Restricted Stock Units
2011-12-05
4
D
0
15000
0
D
Common Stock
15000
0
D
The stock options were cancelled pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Pharmaceutical Product Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger") in exchange for a cash payment equal to the difference (if any ) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 6/17/11, 6/17/12 and 6/17/13 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes.
Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. The RSUs were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but became fully vested pursuant to the terms of the Agreement. The RSUs were disposed of pursuant to the terms of the Agreement in exchange for a cash payment of $33.25 per share upon the effective date of the Merger.
Lisa C. Noecker attorney-in-fact for Christine A. Dingivan
2011-12-06